April 4, 2022 – Congratulations, Dr. David Malkin!

AACR-St. Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research: David Malkin, MD, FRCPC (Photo)
This award recognizes an individual in any sector who has significantly contributed to any area of pediatric cancer research, resulting in the fundamental improvement of the understanding and/or treatment of pediatric cancer.

Click here to read more.


PDF Click here to Download Brief Bio – Dr. Lorne Tyrrell


CONGRATULATIONS,
DR. LORNE TYRRELL

Friends of CIHR is pleased to announce that Dr. David Lorne J. Tyrrell, Distinguished Professor at the University of Alberta, visionary clinician-scientist, creative virologist, entrepreneur and academic leader, is the recipient of the 2021 Henry G. Friesen International Prize in Health Research.

Toronto – December 10, 2021 – Dr. David Lorne J. Tyrrell, OC, AOE, MD, PhD, FRCP, FRSC, FCAHS, is a Distinguished Professor at the University of Alberta with major interests in the prevention and treatment of viral diseases. His multi-faceted career in academic medicine, virology, pharmaceutical enterprise, and dedicated advocacy for health research in Canada are being honoured with the 2021 Henry G. Friesen International Prize in Health Research. Dr. Lorne Tyrrell is a gold medalist at the University of Alberta, where he obtained an MD in 1968 and a PhD at Queen’s University in 1972. He completed Internal Medicine and sub-specialty training in Infectious Diseases and post-doctoral training in Virology at the Karolinska Institute.

Dr. Tyrrell led the Faculty of Medicine and Dentistry from 1994-2004 as Dean. In this capacity, Health Sciences at U Alberta flourished with major capital developments, including the Katz Group – Rexall Centre for Pharmacy and Health Research and the Li Ka Shing Centre for Health Research Innovation. During this period, Dr. Tyrrell assumed national responsibilities and chaired the Association of Canadian Medical Colleges , through which he facilitated the transition of the Medical Research Council to the Canadian Institutes of Health Research (CIHR). Dr. Tyrrell’s leadership style, his prescience and sound judgement led to a number of important Board chairmanships, including the Institute of Health Economics (IHE), the Gairdner Foundation Board and memberships in the Science Advisory Board of Health Canada and the National Vaccine Task Force.

Dr. Tyrrell’s most celebrated life saving accomplishment in collaboration with Morris Robbins was the licensing of the first oral anti-viral drug for chronic HPV (Lamivudine) in 200 countries. This led to the establishment of the Li Ka Shing Institute of Virology in 2010 at the University of Alberta, where Dr. Tyrrell is its Founder and Director.

Dr. Tyrrell has received numerous awards including the Prix Galien Canada Research Award (1998), the Gold Medal of the Canadian Liver Foundation (2000), Alberta Order of Excellence (2000), Officer of the Order of Canada (2002), the Frederic Newton Gisborne Starr Award of the Canadian Medical Association (2004), and Fellow of the Royal Society of Canada (2004). Dr. Tyrrell was inducted into the Canadian Medical Hall of Fame (2011) and he was awarded the Killam Prize for Health Science (2015). In 2018, he received the FCIHR Award of Honour.

Dr. Tyrrell maintains active research programs in viral-host interactions, development of a HCV vaccine and an active program on SARS-CoV-2 vaccines, diagnostics, and antivirals. He has published more than 250 peer-reviewed papers. In his spare time, he tends to his 1000 acre farm.

The Henry G. Friesen International Prize in Health Research, established in 2005 by the Friends of Canadian Institutes of Health Research (FCIHR), recognizes exceptional innovation by a visionary health leader of international stature. The $35,000 Friesen Prize is awarded annually. Dr. Lorne Tyrrell will deliver public talks in 2022 in conjunction with the Friesen Prize Program. For further information on Friends of CIHR and the Friesen International Prize, please visit: www.fcihr.ca or contact: Cristina S. Castellvi. Tel. #: (416) 506-1597. Email: fcihr@fcihr.ca

——————————————————————————————————————–

PDF Annonce – le Dr Lorne Tyrrell


FÉLICITATIONS,
DR LORNE TYRRELL

Les Amis des IRSC ont le plaisir d’annoncer l’attribution du Prix international Henry G. Friesen de la recherche en santé 2021 au Dr David Lorne J. Tyrrell, professeur émérite à l’Université de l’Alberta, clinicien-chercheur visionnaire, virologue créatif, entrepreneur et leader universitaire.

Toronto – le 10 décembre, 2021 – Le Dr David Lorne J. Tyrrell, OC, AOE, MD, PhD, FRCP, FRSC, FCAHS, est professeur émérite à l’Université de l’Alberta et s’intéresse de près à la prévention et au traitement des maladies virales. Sa carrière aux multiples volets en médecine universitaire, virologie, entreprise pharmaceutique et promotion de la recherche en santé au Canada est honorée par le Prix international Henry G. Friesen de la recherche en santé 2021. Le Dr Tyrrell est médaillé d’or à l’Université de l’Alberta et il y a obtenu un doctorat en médecine en 1968 et un doctorat à l’Université Queen’s en 1972. Ses études en médecine interne lui vaudront une sous-spécialité en maladies infectieuses et une formation postdoctorale en virologie à l’Institut Karolinska.

Le Dr Tyrrell a dirigé à titre de doyen la Faculté de médecine et de dentisterie de 1994 à 2004. À ce titre, les sciences de la santé de l’Université de l’Alberta ont prospéré grâce à d’importantes immobilisations nouvelles, notamment le Katz Group – Rexall Centre for Pharmacy and Health Research et le Li Ka Shing Centre for Health Research Innovation. Au cours de cette période, le Dr Tyrrell a assumé des responsabilités nationales et présidé l’Association des facultés de médecine du Canada, qui lui a permis de faciliter la transition du Conseil de la recherche médicale aux instituts de recherche en santé du Canada (IRSC). Le style de leadership du Dr Tyrrell, sa préscience et son bon jugement ont mené à diverses présidences importantes de conseils d’administration, dont celle de l’Institut d’économie de la santé (IHE) et de la Fondation Gairdner ainsi que l’appartenance au Conseil consultatif scientifique de Santé Canada et au Groupe de travail national sur les vaccins.

La réalisation la plus notoire du Dr Tyrrell, en collaboration avec Morris Robbins, a été l’homologation dans 200 pays du premier médicament antiviral oral contre le VPH chronique (Lamivudine), qui a amené la création de l’Institut de virologie Li Ka Shing en 2010 à l’Université de l’Alberta, dont le Dr Tyrrell est à la fois fondateur et directeur.

Le Dr Tyrrell est titulaire de nombreux prix, dont le Prix Galien Canada pour la recherche (1998), la Médaille d’or de la Fondation canadienne du foie (2000), l’Ordre d’excellence de l’Alberta (2000), le Prix Frederic Newton Gisborne Starr de l’Association médicale canadienne (2004), le titre d’officier de l’Ordre du Canada (2002) et celui de membre de la Société royale du Canada (2004). Le Dr Tyrrell a été intronisé au Temple de la renommée médicale canadienne (2011) et il a reçu le prix Killam pour les sciences de la santé (2015). En 2018, la FCIHR lui a décerné le prix d’honneur.

Le Dr Tyrrell poursuit des programmes de recherche actifs sur les interactions virus-hôte, la mise au point d’un vaccin contre le VHC et un programme actif sur les vaccins, diagnostics et antiviraux contre le SRAS-CoV-2. Il a publié plus de 250 articles évalués par des pairs. Dans ses temps libres, il exploite sa ferme de 1000 acres.

Le Prix international Henry G. Friesen de la recherche en santé, créé en 2005 par les Amis des Instituts de recherche en santé du Canada (EDSI), reconnaît l’innovation exceptionnelle d’un chef de file visionnaire d’envergure internationale en santé. Le prix Friesen, doté de 35 000 $, est décerné chaque année. Le Dr Lorne Tyrrell prononcera des conférences publiques en 2022 dans le cadre du programme concernant ce prix. Pour de plus amples renseignements sur les Amis des IRSC et le Prix international Friesen, veuillez consulter www.fcihr.ca ou communiquer avec Cristina S. Castellvi (tél. 416-506-1597 et courriel : fcihr@fcihr.ca).

——————————————————————————————————————–

Dr. David MalkinDr. David Malkin, clinician-scientist, cancer physician and academic leader, is appointed 2nd President of Friends of CIHR
PDF Click here to Download Announcement

Toronto – October 15, 2021 – The Board of Directors of Friends of Canadian Institutes of Health Research (FCIHR) is pleased to announce that Dr. David Malkin, MD, FRCPC is appointed President and Board Chair of FCIHR – effective January 1, 2022. Dr. Malkin is a pediatric oncologist, an active clinician-scientist, a committed educator and an accomplished administrative leader.

Dr. Malkin is Professor of Pediatrics and Medical Biophysics in the Faculty of Medicine at the University of Toronto and is the CIBC Children’s Foundation Chair in Child Health Research, Director of the Cancer Genetics Program, and co-lead of the Precision Child Health initiative at the Hospital for Sick Children. In addition, he leads regional and national programs in precision oncology for children, adolescents and young adult cancer patients with the aim to transform the outcomes for these patients. Dr. Malkin’s research program focuses on genetic and genomic mechanisms of childhood cancer susceptibility, advances from which have led him to receive many awards and recognitions.

Dr. Malkin succeeds Dr. Aubie Angel, founding President of FCIHR, who notes:
“I am delighted with this Appointment as Dr. David Malkin brings new energy and perspective to the vision and mission of FCIHR and will provide fresh leadership and direction for the many members of our vibrant enterprise”.

FCIHR is a national not-for-profit organization that was established in 2000 to support the goals and ideals of the Canadian Institutes of Health Research (CIHR) and to communicate the value of health research to a broad, multifaceted public audience. Through a spectrum of programs, FCIHR also seeks to attract and support young health science trainees and scientists in their career development. The Henry G. Friesen International Prize in Health Research program, which began in 2006 and which includes visits and scholarly events in Canadian universities, exemplifies our mission. FCIHR also convenes public gatherings and roundtables of experts to discuss important health sciences issues of the day, and therein collaborates with like-minded Canadian health science organizations in all sectors.

For further information on Friends of CIHR and its various programs, please visit: www.fcihr.ca or contact: Cristina S. Castellvi. Tel. #: (416) 506-1597. Email: fcihr@fcihr.ca

——————————————————————————————————————–

21st Anniversary - FCIHR
Friends of CIHR (FCIHR)
was created to promote the value of health research and establish community-based partnerships. Since 2000, it has specifically supported the goals and initiatives of the Canadian Institutes of Health Research (CIHR) and has expanded its role to represent all health disciplines. The 16-person Board of Directors represents a membership active in universities, hospitals, voluntary organizations, community groups and agencies, as well as some private corporations. In addition, Friends of CIHR promotes research funding with all levels of government. FCIHR organizes annual educational symposia and publishes the proceedings for wide distribution. The Video History of Medicine in Canada is the latest innovative program conceived by the group. Friends of CIHR is a non-profit, non-governmental, incorporated organization.

Les Amis des Instituts de recherche en santé du Canada (AIRSC) est un organisme créé dans le but de promouvoir la valeur de la recherche en santé et d’établir des partenariats communautaires. Depuis 2000, l’organisme a expressément appuyé les objectifs et les initiatives des Instituts de recherche en santé du Canada (IRSC) et a élargi son rôle afin de représenter toutes les disciplines de la santé. Le conseil d’administration, comprenant 16 membres, représente des adhérents qui œuvrent dans des universités, des hôpitaux, des organismes bénévoles, des groupes et organismes communautaires et des sociétés privées. En plus de promouvoir le financement de la recherche à tous les niveaux de gouvernement, les AIRSC présentent chaque année des colloques pédagogiques et en publient les procès-verbaux. L’Histoire de la médecine au Canada est le dernier programme novateur réalisé en collaboration par le groupe. Les Amis des IRSC est un organisme non gouvernemental sans but lucratif constitué en personne morale.